---
$id: https://graph.org.ai/products/commodity/51131656
$type: Product
source: UNSPSC
code: "51131656"
title: "Vapiprost"
class: "51131600"
classTitle: "Anticoagulants"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Vapiprost

**UNSPSC Code**: 51131656
**Class**: [Anticoagulants](Anticoagulants.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiplatelet agent with the molecular formula C30H39NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H84XT1COAU, chemically known as 4-heptenoic acid, 7-(5-((1,1-biphenyl)-4-ylmethoxy)-3-hydroxy-2-(1-piperidinyl)cyclopentyl)-, (1r-(1alpha(z),2beta,3beta,5alpha))- but generally known as vapiprost, which bears US NIH Compound Identifier 6436588. European Medicines Agency schedules Vapiprost in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00025MIG. The term VAPIPROST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). VAPIPROST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule vapiprost under HS 29375000 and SITC 54156. As of Q4 2014, VAPIPROST remains the US FDA Preferred Term for this commodity. Vapiprost bears US NLM identifiers UMLS ID C0061849 and NCI Concept Code C76408. SMILES: O(C1C(C(N2CCCCC2)C(O)C1)CC/C=C/CCC(=O)O)CC1CCC(CC1)C1CCCCC1.

